drugset / Trial / NCT01634529

Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers

NCT01634529 ↗

Phase 1 Completed 50 enrolled Vernalis (R&D) Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate whether V158866 is safe when given to healthy male subjects in single and multiple doses.

Timeline

Start
2011-03
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject V158866 Unknown — Oral

Indications

No indication recorded.